Eric Fink is co-CEO and Managing Partner at Slone Partners. He has nearly 25 years of diversified experience building and scaling teams, capabilities, and companies across various functional areas and stages, evolving global life sciences companies from start-up through mid-cap. As co-CEO, Eric helps guide the company’s strategic business planning and operations, and oversees its Fractional Talent service. Prior to joining Slone Partners, Eric served as COO of ABio-X Holdings, a private Boston-based investment and incubation company, where he built and scaled the G&A and operating functions of the company and its portfolio companies. Before that, Eric served as Chief Human Resources Officer at Silence Therapeutics; Chief Human Resources Officer at Freeline Therapeutics; Executive Vice President, Chief Human Resources Officer at Global Blood Therapeutics; and in a variety of leadership roles ending as Vice President, Human Resources at Jazz Pharmaceuticals. Eric earned his B.S. in Biology from Pennsylvania State University and his M.S. in Organizational Leadership from Mercyhurst College.